Solara Active PP

How has been the historical performance of the Solara Active PP?

No Data Available for this Stock

how big is Solara Active PP?

As of June 06, Solara Active Pharma Sciences Ltd Partly Paidup has a market capitalization of 389.00 Cr, categorizing it as a Micro Cap. There is no available financial data for the latest four quarters or balance sheet information.

Market Cap: As of June 06, Solara Active Pharma Sciences Ltd Partly Paidup has a market capitalization of 389.00 Cr, categorizing it as a Micro Cap.<BR><BR>Recent Quarterly Performance: As of June 06, there is no valid Consolidated or Standalone financial data available for the latest four quarters, including Net Sales and Net Profit.<BR><BR>Balance Sheet Snapshot: As of June 06, there is no valid Consolidated or Standalone balance sheet data available, including values for Shareholder's Funds and Total Assets for the latest annual period.

When is the next results date for Solara Active PP?

No Upcoming Board Meetings

Has Solara Active PP declared dividend?

No Dividend History Available

What is the technical trend for Solara Active PP?

As of June 4, 2025, Solara Active PP shows a neutral trend with a slight bullish inclination due to a mildly bullish weekly MACD and RSI, despite daily moving averages being mildly bearish and no clear trend from Dow Theory and OBV.

As of 4 June 2025, the technical trend for Solara Active PP has changed from mildly bearish to sideways. The weekly MACD is mildly bullish, and the RSI is bullish, indicating some positive momentum in the short term. However, daily moving averages are mildly bearish, suggesting caution. The Bollinger Bands on the weekly chart are also bullish, supporting the upward potential. Dow Theory and OBV show no clear trend in both weekly and monthly time frames, indicating a lack of strong directional movement. Overall, the current stance is neutral with a slight bullish inclination, driven primarily by the weekly MACD and RSI.

Who are the peers of the Solara Active PP?

Peers of Solara Active PP include Venus Remedies, Ind-Swift Labs, Jenburkt Pharma, Zim Laboratories, Albert David, Medicamen Biotec, Valiant Laborato, Brooks Lab, Nectar Lifesci, and Infinium Pharma. Jenburkt Pharma has the highest 1-year return at 47.73%, while Solara Active PP leads with 59.14%.

Peers: The peers of Solara Active PP are Venus Remedies, Ind-Swift Labs., Jenburkt Pharma, Zim Laboratories, Albert David, Medicamen Biotec, Valiant Laborato, Brooks Lab., Nectar Lifesci., and Infinium Pharma.<BR><BR>Quality Snapshot: Excellent management risk is observed at Infinium Pharma, while Average management risk is found at Venus Remedies, Jenburkt Pharma, Zim Laboratories, Albert David, Medicamen Biotec, and the rest. Below Average management risk is present at Ind-Swift Labs., Valiant Laborato, Brooks Lab., and Nectar Lifesci. Growth is rated as Excellent for Venus Remedies, Jenburkt Pharma, Albert David, Medicamen Biotec, and the rest show Below Average growth, including Ind-Swift Labs., Zim Laboratories, and Valiant Laborato. Infinium Pharma stands out with Good growth. Capital Structure is Excellent for Venus Remedies, Jenburkt Pharma, Albert David, Medicamen Biotec, and the rest, while Average is noted for Zim Laboratories, and Below Average for Ind-Swift Labs., Valiant Laborato, Brooks Lab., and Nectar Lifesci.<BR><BR>Return Snapshot: The peer with the highest 1-year return is Jenburkt Pharma at 47.73%, while Ind-Swift Labs. has the lowest at -26.31%. Solara Active PP's 1-year return of 59.14% is higher than both of these peers. Additionally, several peers, including Ind-Swift Labs., Albert David, Medicamen Biotec, Valiant Laborato, Brooks Lab., Nectar Lifesci., and Infinium Pharma, have negative six-month returns.

What does Solara Active PP do?

Solara Active Pharma Sciences Ltd Partly Paidup is a micro-cap company in the Pharmaceuticals & Biotechnology sector with no reported sales or profits. It has a market cap of INR 541 Cr and key metrics such as a P/E ratio and dividend yield of 0.00%.

Overview: <BR>Solara Active Pharma Sciences Ltd Partly Paidup operates in the Pharmaceuticals & Biotechnology industry and is categorized as a Micro Cap company.<BR><BR>History: <BR>The incorporation year and any status changes are not provided. There are no reported sales or profit figures for the latest quarter.<BR><BR>Financial Snapshot: <BR>Most recent Net Sales: N/A <BR>Most recent Net Profit: N/A <BR>Market-cap value: INR 541 Cr (Micro Cap)<BR><BR>Key Metrics: <BR>P/E: N/A <BR>Industry P/E: 37 <BR>Dividend Yield: 0.00% <BR>Debt-Equity: 0.00 <BR>Return on Equity: 0.00% <BR>Price-to-Book: 0.00<BR><BR>Contact Details: <BR>Registrar Address: Not available. <BR>Phone: Not available. <BR>Email: Not available. <BR>Website: Not available.

Which are the latest news on Solara Active PP?

Why is Solara Active Pharma Sciences Ltd Partly Paidup falling/rising?

As of 03-Jun, the stock price of Solara Active Pharma Sciences Ltd Partly Paidup is at 308.70, showing a positive intraday performance but a year-to-date decline of 18.78%. Despite today's gains, decreasing investor participation and longer-term downward trends suggest potential weakness in the stock's performance.

As of 03-Jun, the stock price of Solara Active Pharma Sciences Ltd Partly Paidup is currently at 308.70, with no change from the previous trading session. The stock has shown a performance today that outperformed its sector by 13.15%, indicating a positive movement relative to its peers. It opened with a significant gain of 12.87%, reaching an intraday high of Rs 308.70. However, despite this positive performance today, the stock has been experiencing a decline over a longer period, with a year-to-date decrease of 18.78% and a one-year decline of 9.84%.<BR><BR>The stock's trading activity has been erratic, as it did not trade on one day out of the last 20 days. Additionally, there has been a notable decrease in investor participation, with delivery volume falling by 14.1% against the 5-day average. This decline in delivery volume suggests reduced investor interest, which could contribute to the stock's overall downward trend despite today's gains. Furthermore, while the stock is currently trading above its 5-day and 20-day moving averages, it remains below its longer-term moving averages, indicating potential weakness in the stock's performance over time. <BR><BR>In summary, while there was a positive spike in the stock price today, the overall trend indicates a decline in value over the year, coupled with decreasing investor participation, which may explain the mixed signals regarding its performance.